Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Dec 11, 2007 by Edgar Snyder

Bed-Wetting Drug Linked to Seizures

Bed-Wetting Drug

The Food and Drug Administration (FDA) has warned parents and healthcare professionals that seizures may result form a drug commonly prescribed to children to control bed-wetting. Desmopressin, sold as DDAVP, DDVP, Stimate, and more, may lead to seizures and death among young children who take the intranasal drug.

Desmopressin is most often taken as a nasal spray formula. The drug is used to treat nocturnal enuresis, commonly known as bed-wetting. This FDA warning seeks to curb negative affects resulting from the use of desmopressin.

The drug has been linked to a condition known as hyponatremia. Serious hyponatremia illness may lead to seizures, a dangerous side effect particularly among children and patients in a weakened state. In severe cases, the condition can lead to death.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Maryland, Ohio, Virginia, and West Virginia, and we associate with experienced attorneys in other states. In addition, all drug-related litigation may involve co-counsel.

Source: "Desmopressin Acetate." FDA Alert. December 4, 2007.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Sep 16, 2016
New CDC Tool Will Help Keep Traveling Workers Safe
Sep 14, 2016
PA Residents: You're This Much More Likely to Hit a Deer